HELXvsPBEETF Comparison
Franklin Genomic Advancements ETF (HELX) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. HELX's top 3 sector exposures are Health Care, Materials and Information Technology. In contrast, PBE's top sector exposures are Health Care, HELX is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.58% for PBE. HELX is down -1.22% year-to-date (YTD) with +$2M in YTD flows. PBE performs better with 3.55% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of HELX and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
HELX vs PBE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX PBE | +9.44%+5.04% | +10.46%+9.99% | -1.22%+3.55% | +30.57%+33.11% | +14.77%+35.81% | -22.60%+12.88% |
| Flows | HELX PBE | -+$2M | --$3M | +$2M-$3M | +$8M-$25M | +$9M-$56M | +$14M-$45M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX PBE | +26.51%+19.90% | +21.11%+19.09% | +20.62%+20.14% | +23.64%+22.41% |
| Max drawdown | HELX PBE | -6.54%-4.08% | -17.89%-11.70% | -29.16%-22.21% | -58.50%-34.74% |
| Max drawdown duration | HELX PBE | 38d16d | 197d159d | 458d324d | 1742d1540d |
HELX | PBE | |
Last sale 6/15/2026 at 2:14 PM | $35.82 | $84.64 |
| Previous close 06/15/2026 | $35.45 | $84.10 |
| Consolidated volume 06/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HELX | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HELX | PBE | |
|---|---|---|
| Last price | $35.82 | $84.64 |
| 1D performance | +1.03% | +0.64% |
| AuM | $23.30 M | $262.42 M |
| E/R | 0.5% | 0.58% |
HELX | PBE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Franklin Templeton | Invesco |
| Benchmark | - | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 50 | 30 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | June 23, 2005 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
